This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SurgiCount Medical To Sponsor The Inaugural Patient Safety, Science & Technology Summit Founded By The Masimo Foundation For Ethics, Innovation & Competition In Healthcare

Stocks in this article: MASI PSTX

IRVINE, Calif., Jan. 11, 2013 /PRNewswire/ -- SurgiCount Medical, Inc. (the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTCBB: PSTX, OTCQB: PSTX) today announced that it is joining a list of Committed Partners in sponsoring the inaugural Patient Safety, Science & Technology Summit.  Founded by the Masimo Foundation for Ethics, Innovation & Competition in Healthcare, the event is focused on confronting large patient safety issues with actionable ideas and innovations that can help transform the process of care for dynamic improvements in patient safety and cost of care.  President Bill Clinton headlines the event as the Keynote Speaker and is joined by a list of other speakers and panelists including Dr. Peter J. Pronovost, the Senior Vice President for Patient Safety and Quality at Johns Hopkins, and Joe Kiani, the founder and CEO of Masimo (NASDAQ: MASI) and Chairman of the Masimo Foundation.  The event is scheduled for January 13-14 at the Ritz Carlton in Laguna Niguel, CA. 

"We are proud to support the Masimo Foundation in its call to action to address preventable patient injuries and the real human and economic costs of their occurrence.  We look forward to helping enable and participating in the dialogue among other medical device technology companies, clinicians, hospitals, payers and government as we work toward providing actionable solutions to both improve patient safety and reduce healthcare costs," stated Brian E. Stewart, President and Chief Executive Officer of Patient Safety Technologies, Inc.  "As the provider of the market leading solution to the most commonly reported surgical adverse event, we believe we are in a unique position to play an integral role in helping achieve these goals and look forward to continuing to support the Masimo Foundation"         

About Patient Safety Technologies, Inc. and SurgiCount Medical Patient Safety Technologies, Inc., through its wholly-owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge ® System, a solution clinically proven to improve patient safety and reduce healthcare costs by helping prevent the most commonly reported surgical adverse event, retained surgical sponges.  For more information, contact SurgiCount Medical, Inc. at (949) 387-2277 or visit www.surgicountmedical.com.

About the Patient Safety, Science & Technology Summit Improving patient safety is one of the greatest challenges facing the healthcare industry.  Cost-effectively solving patient safety challenges requires fundamental changes in the process of care and a collaborative effort from all stakeholders.  Founded by the Masimo Foundation for Ethics, Innovation & Competition in Healthcare, the Patient Safety, Science & Technology Summit is designed to unite and educate the healthcare industry (medical technology companies, clinicians, hospitals, payers, and government) toward actionable, high impact patient safety solutions. Focused on connecting ideas, people and technologies in order to connect the dots in patient care through monitoring and feedback, predicting risk, therapeutic advances, decision support, interoperability, automating and integrating quality measures, the Summit will deliver high impact patient safety recipes each year. For more information, visit www.patientsafetysummit.com.

Forward Looking Statements



1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs